Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Rebecca Leaman

Rebecca Leaman is a masters candidate in Global Affairs from New York University.

Articles by Rebecca Leaman

Feeling Lucky? Convergence Mental Health as a Mechanism for Serendipitous Innovation

ByErin Smith,Jessica Carson,Rebecca Leaman,William Hynes, DPhil,Helen Lavretsky, MD, MS,Michael Berk, MD, PhD,Harris A. Eyre, MD, PhD

March 23rd 2021

This mindset might be the key to mental health breakthroughs.

Latest Updated Articles

Trending on Psychiatric Times

Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases

Preliminary Report on Dangers of AI Chatbots

The Trial of ChatGPT: What Psychiatrists Need to Know About AI, Suicide, and the Law

6 Helpful Pearls From the International Guidelines for Algorithmic Treatment of Schizophrenia

Suicide: Can Emergency Departments Assist in its Prevention?

© 2025 MJH Life Sciences^®

All rights reserved.